A novel pathway for microbial metabolism of levodopa

Particular bacteria from the gut microbiota metabolize levodopa (l-dopa), reducing bioavailability of the drug for treating Parkinson’s disease.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Redkal et al. identify a novel pathway for microbial metabolism of l-dopa.


  1. 1.

    Sampson, T. R. et al. Cell 167, 1469–1480.e12 (2016).

    CAS  Article  Google Scholar 

  2. 2.

    Papavasiliou, P. S. et al. N. Engl. J. Med. 286, 8–14 (1972).

    CAS  Article  Google Scholar 

  3. 3.

    Bedarf, J. R. et al. Genome Med. 9, 39 (2017).

    CAS  Article  Google Scholar 

  4. 4.

    Hashim, H. et al. PLOS One 9, e112330 (2014).

    Article  Google Scholar 

  5. 5.

    Fasano, A. et al. Mov. Disord. 28, 1241–1249 (2013).

    CAS  Article  Google Scholar 

  6. 6.

    Zhu, H. et al. Sci. Rep. 6, 27779 (2016).

    CAS  Article  Google Scholar 

  7. 7.

    Whitfield, A. C. et al. ACS Chem. Neurosci. 5, 1192–1197 (2014).

    CAS  Article  Google Scholar 

  8. 8.

    Zimmermann, M. et al. Nature 570, 462–467 (2019).

    CAS  Article  Google Scholar 

  9. 9.

    Zimmermann, M. et al. Science 363, 6427 (2019).

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to K. G. Jameson.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jameson, K.G., Hsiao, E.Y. A novel pathway for microbial metabolism of levodopa. Nat Med 25, 1195–1197 (2019).

Download citation


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing